BOZZARELLI, SILVIA

BOZZARELLI, SILVIA  

Universita' degli Studi di MILANO  

Mostra records
Risultati 1 - 8 di 8 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Phase II Study of Tivantinib and Cetuximab in Patients With KRAS Wild-type Metastatic Colorectal Cancer With Acquired Resistance to EGFR Inhibitors and Emergence of MET Overexpression : lesson Learned for Future Trials With EGFR/MET Dual Inhibition 2019 Bozzarelli, SilviaPietrantonio, FilippoGiordano, LauraDi Tommaso, Luca + Article (author) -
Estimating 12-week death probability in patients with refractory metastatic colorectal cancer: the Colon Life nomogram 2017 Pietrantonio, FMennitto, ABozzarelli, Sde Braud, F + Article (author) -
Outcomes of advanced gastric cancer patients treated with at least three lines of systemic chemotherapy 2017 Pietrantonio, FilippoFerrari, LauraBozzarelli, Silvia + Article (author) -
KRAS mutation in lung metastases from colorectal cancer : Prognostic implications 2016 M. GhidiniN. PersoneniS. BozzarelliM. BarettiT. PressianiA. Malesci + Article (author) -
A new nomogram for estimating survival in patients with brain metastases secondary to colorectal cancer 2015 F. PietrantonioP. BiondaniNIGER, MONICAGHIDINI, MICHELEBOZZARELLI, SILVIAF. De Braud + Article (author) -
FOLFIRI and Cetuximab Every Second Week for First-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer According to Phosphatase and Tensin Homolog Expression : a Phase II Study 2015 N. PersoneniL. RubinoS. BozzarelliA. DestroC. Raschioni + Article (author) -
Molecular determinants of outcome in sorafenib-treated patients with hepatocellular carcinoma 2013 N. PersoneniT. PressianiA. DestroS. BozzarelliL. Di TommasoL. GiordanoM. Roncalli + Article (author) -
Usefulness of alpha-fetoprotein response in patients treated with sorafenib for advanced hepatocellular carcinoma 2012 N. PersoneniS. BozzarelliT. PressianiF. Sclafani + Article (author) -